SCHEMBL7982708

SCHEMBL7982708

C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SC(CO)Cc3ccccn3)[C@H](C)[C@H]12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.43
PTGS1 P23219 1/20 0.43
PDE4A P27815 1/20 0.43
CACNA1C Q13936 1/20 0.42
ABCC2 Q92887 1/20 0.38
PTPRA P18433 1/20 0.37
CTRB1 P17538 1/20 0.34
TSHR P16473 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
FAP Q12884 1/20 0.32
HTT P42858 2/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ELANE P08246 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982997 0.90 ESR1 (0.45) ESR1PTGS1PDE4ACACNA1CABCC2
SCHEMBL7986868 0.90 ESR1 (0.45) ESR1PTGS1PDE4ACACNA1CABCC2
SCHEMBL7982994 0.90 ESR1 (0.45) ESR1PTGS1PDE4ACACNA1CABCC2
SCHEMBL10440442 0.84 ESR1 (0.44) ESR1PTGS1PDE4ACACNA1CABCC2
SCHEMBL7979861 0.82 CACNA1C (0.42) ESR1PTGS1PDE4ACACNA1CABCC2
SCHEMBL22166268 0.79 ESR1 (0.46) ESR1PTGS1PDE4ACACNA1CABCC2
SCHEMBL7979469 0.78 ESR1 (0.44) ESR1PTGS1PDE4ACACNA1CABCC2
SCHEMBL7969446 0.78 ESR1 (0.44) ESR1PTGS1PDE4ACACNA1CABCC2
SCHEMBL9696455 0.77 ESR1 (0.44) ESR1PTGS1PDE4ACACNA1CABCC2
SCHEMBL11948533 0.77 ESR1 (0.37) ESR1PTGS1PDE4ACACNA1CPTPRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6174877-B1 EXCELLANT BACTERICIDES, ORAL ABSORBABILITY AND STABILITY; IMPROVE THE STABILITY TO RENAL DEHYDROPEPTIDASE I (DHP-I); 2-(2-(N-HETEROCYCLIC-ETHYLTHIO-) DERIVATIVES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-01-16 US disclosed